Cabo Verde

Reimbursed Care Access

Cabo Verde operates under a regulatory and penal framework that criminalizes the unauthorised possession, sale and trafficking of narcotics and psychotropic substances; classical psychedelic compounds (psilocybin, MDMA, mescaline, DMT/5‑MeO‑DMT, 2C‑X family, ibogaine, ayahuasca) are treated as controlled/illicit under national law with no routine medical reimbursement or broad clinical access. Ketamine is recognized as an essential/medical anesthetic agent globally and medicines regulation in Cabo Verde is centralized under national health regulatory authorities, but there is no published evidence of approved, reimbursed psychedelic‑assisted medicine programs (e.g., esketamine for TRD) or a national reimbursement pathway for psychedelic therapies as of the sources checked.